Asuragen and Illumina will join forces to develop and commercialise plasma - based companion diagnostics . The partnership will utilise hp 's Quantidex NGS product platform in conjunction with Illumina 's MiSeqDx product .
Asuragen and Illumina will join forces to develop and commercialise genomics-based companion diagnostics. The partnership will utilise Asurgen's Quantidex NGS product platform in conjunction with Illumina's MiSeqDx instrument.